CD274 and neoplasm: Of note, Yang et al. developed a selective HDAC8 inhibitor which potentiated eradication of established hepatomas by anti-PD-L1 therapy, and the HSCC murine models receiving the combination therapy remained tumor-free for more than 15 months [323].